Phibro Animal Health Future Growth
Future criteria checks 3/6
Phibro Animal Health is forecast to grow earnings and revenue by 33.2% and 3.1% per annum respectively. EPS is expected to grow by 33.3% per annum. Return on equity is forecast to be 18% in 3 years.
Key information
33.2%
Earnings growth rate
33.3%
EPS growth rate
| Pharmaceuticals earnings growth | 20.3% |
| Revenue growth rate | 3.1% |
| Future return on equity | 18.0% |
| Analyst coverage | Low |
| Last updated | 06 Mar 2024 |
Recent future growth updates
Recent updates
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10
Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12
Nov 05We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed
Oct 26Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?
Aug 26Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
Jul 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 1,062 | 36 | 21 | 99 | 2 |
| 6/30/2025 | 1,029 | 29 | 16 | 86 | 3 |
| 6/30/2024 | 998 | 15 | 37 | 103 | 3 |
| 12/31/2023 | 982 | 15 | 37 | 74 | N/A |
| 9/30/2023 | 977 | 21 | 4 | 40 | N/A |
| 6/30/2023 | 978 | 33 | -38 | 13 | N/A |
| 3/31/2023 | 978 | 29 | -58 | -5 | N/A |
| 12/31/2022 | 972 | 36 | -60 | -5 | N/A |
| 9/30/2022 | 960 | 46 | -36 | 17 | N/A |
| 6/30/2022 | 942 | 49 | -5 | 32 | N/A |
| 3/31/2022 | 907 | 59 | 1 | 33 | N/A |
| 12/31/2021 | 879 | 53 | 14 | 44 | N/A |
| 9/30/2021 | 853 | 49 | 21 | 50 | N/A |
| 6/30/2021 | 833 | 54 | 19 | 48 | N/A |
| 3/31/2021 | 799 | 43 | 17 | 49 | N/A |
| 12/31/2020 | 798 | 44 | 27 | 59 | N/A |
| 9/30/2020 | 806 | 43 | 31 | 65 | N/A |
| 6/30/2020 | 800 | 34 | 25 | 59 | N/A |
| 3/31/2020 | 818 | 37 | 36 | 70 | N/A |
| 12/31/2019 | 813 | 38 | 25 | 59 | N/A |
| 9/30/2019 | 818 | 41 | 11 | 42 | N/A |
| 6/30/2019 | 828 | 55 | 17 | 47 | N/A |
| 3/31/2019 | 836 | 68 | 17 | 42 | N/A |
| 12/31/2018 | 839 | 73 | 28 | 50 | N/A |
| 9/30/2018 | 827 | 65 | 47 | 66 | N/A |
| 6/30/2018 | 820 | 65 | 51 | 70 | N/A |
| 3/31/2018 | 803 | 58 | 55 | 73 | N/A |
| 12/31/2017 | 784 | 62 | 69 | 88 | N/A |
| 9/30/2017 | 770 | 68 | N/A | 82 | N/A |
| 6/30/2017 | 764 | 65 | N/A | 98 | N/A |
| 3/31/2017 | 759 | 64 | N/A | 111 | N/A |
| 12/31/2016 | 752 | 59 | N/A | 79 | N/A |
| 9/30/2016 | 752 | 76 | N/A | 61 | N/A |
| 6/30/2016 | 752 | 83 | N/A | 37 | N/A |
| 3/31/2016 | 747 | 78 | N/A | 32 | N/A |
| 12/31/2015 | 751 | 76 | N/A | 49 | N/A |
| 9/30/2015 | 748 | 60 | N/A | 49 | N/A |
| 6/30/2015 | 749 | 60 | N/A | 69 | N/A |
| 3/31/2015 | 747 | 32 | N/A | 30 | N/A |
| 12/31/2014 | 733 | 22 | N/A | 9 | N/A |
| 9/30/2014 | 717 | 10 | N/A | 17 | N/A |
| 6/30/2014 | 692 | -3 | N/A | -1 | N/A |
| 3/31/2014 | 672 | 20 | N/A | 27 | N/A |
| 12/31/2013 | 662 | 18 | N/A | 20 | N/A |
| 9/30/2013 | 652 | 23 | N/A | 2 | N/A |
| 6/30/2013 | 653 | 25 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PAHC's forecast earnings growth (33.2% per year) is above the savings rate (2.3%).
Earnings vs Market: PAHC's earnings (33.2% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: PAHC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PAHC's revenue (3.1% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: PAHC's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PAHC's Return on Equity is forecast to be low in 3 years time (18%).